The Hidden Pitfalls of Clinical Trial Activation: A Structural Analysis

Written by

in

TL;DR

  • Clinical trial protocols often require substantial amendments due to structural issues, not procedural ones.
  • Disconnected document review is a major contributor to rework and delays in research sites.

Summary

Clinical trial activation is a critical phase in the research process, but it's often plagued by inefficiencies and delays. A recent analysis reveals that nearly all clinical trial protocols require at least one substantial amendment, which sends research sites back through work they've already completed. This rework is not random, but rather a direct result of how sites handle study documents during activation. In this article, we'll delve into the structural issues that contribute to these problems and explore strategies for improvement.

Content

The reporting details a staggering statistic: over 75% of clinical trial protocols require at least one substantial amendment. But what's driving this trend? According to the original piece, the issue lies in the way research sites handle study documents during activation. Specifically, the problem is rooted in parallel, disconnected document review. Pharmacy staff review the protocol for dosing schedules, while regulatory coordinators review it for compliance. This siloed approach creates a perfect storm of errors and inconsistencies, which ultimately lead to rework and delays. By examining the broader implications of this issue, we can begin to understand the root causes and develop strategies for improvement. One potential solution is to implement a more integrated approach to document review, where all stakeholders are involved from the outset. This could involve creating a single, unified protocol that addresses all aspects of the study, rather than separate documents for different teams. By streamlining the document review process and promoting collaboration among stakeholders, research sites can reduce the likelihood of substantial amendments and minimize the rework that comes with them.

ICYMI

  • Clinical trial protocols often require substantial amendments due to structural issues, not procedural ones.
  • Disconnected document review is a major contributor to rework and delays in research sites.
  • Implementing a more integrated approach to document review can help reduce the likelihood of substantial amendments and minimize rework.

Original Post is from: The Clinical Trial Vanguard
Read it here

See this article here: